Supernus Pharma (SUPN) Tops Q1 EPS by 16c, Beats on Revenues; Offers FY18 Revenue Mid-Point Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. NVDA
5. AMD
6. USO
7. AMC
8. META
9. MSFT
10. AMZN

Go back to Supernus Pharma (SUPN) Tops Q1 EPS by 16c, Beats on Revenues; Offers FY18 Revenue Mid-Point Outlook Below Consensus
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 42.42 +0.42 (1.00%)
Previous Close $42.00    52 Week High $26.84 
Open $42.00    52 Week Low $9.51 
Day High $42.97    P/E N/A 
Day Low $41.68    EPS $-2.62 
Volume 296,107